SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : ADVR - Bulls no Bears

 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: DAN LITTLE who wrote (833)9/29/1997 2:07:00 PM
From: Kingfisher   of 913
 
Dan, Dr. Hirschman had to be well aware of the FDA problems when he took over ADVR,
but even more than that he, most probably, has well prepared himself for the challenge to
satisfy FDA requirements. Dr. Hirschman is a SUPERSTAR. He has all the necessary
human virtues, e.g., hard working, patients, sound research approaches and habits,
knowledge of the scientific and financial problems facing the company and total awareness
of his surroundings and the needs and desires of his associates along with the shareholders
that have put their faith in him.

In addition, I feel that Dr. Hirschman recognizes that the hand of God played an integral part
in the development of Reticulose because he has publicly acknowledged that Dr. LaPenta
[inventor] in the 1930s did not have the technology nor the scientific tools to determine what
Reticulose is and how it works.

Because of Dr. Hirschman's outstanding character along with the recognition of his conspicuous
accomplishments, it is my opinion that the powers-to-be at the FDA had better approve the use
of Reticulose soon or get out of the way. The persistence and dedication that is imbedded in
Dr. Hirschman will be more than enough to lambaste the FDA if they continue to delay approval.

If Dr. Hirschman finds it necessary to begin to play hardball with the FDA and does so with the
passion and enthusiasm he demonstrates in his personal life and his work, he will raise such
havoc for the FDA that only God knows what will happen. Keep in mind that we are talking
possible CANCER cure. Since something like 1-in-4 of us can be inflicted with CANCER,
everyone in this country well be very interested in any FDA confrontation. After the public is
made well aware of what Reticulose means to the treatment of CANCER, what sort of leg will the
FDA have to stand on for not approving Reticulose?

The irony here is that the FDA must have realized, for greater than 1-year now, all that I post here
regarding Dr. Hirschman's character and his scientific findings. They must know the worth of
Reticulose in treating VIRUS infection and CANCER but they seem to be continuing their 1962
decision to suppress the use of Reticulose. It is my opinion that they are continuing to
DEMONSTRATE IRRESPONSIBLE BEHAVIOR < to say the least because Reticulose
can reduce human suffering and save human lives. If the FDA continues to suppress Reticulose
the level of their deportment will be automatically elevated to incompetent or even
unscrupulous behavior.

The Kingfisher
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext